In the context of assisted reproduction treatments, in vitro fertilization (IVF) sometimes involves controlled ovarian stimulation, and one of the known complications of this stage is ovarian hyperstimulation syndrome. Although most forms are mild and resolve under medical supervision, it is important for this reaction to be recognized in time, especially when symptoms become more intense or appear after egg retrieval.

What Ovarian Hyperstimulation Syndrome Is and Why It Occurs

Ovarian hyperstimulation syndrome is a complication associated with the hormonal treatments used to stimulate the ovaries, especially in assisted reproduction protocols. In short, the ovaries respond excessively to the administered medication, increase in volume and may cause fluid to move from the blood vessels into the abdomen or, in more severe forms, into other spaces of the body. This reaction does not occur in all patients, but the risk is known and is part of the careful monitoring of a treatment cycle.

In practice, the risk may be higher in patients with a strong ovarian response, in those with polycystic ovaries or in those who produce a very high number of follicles during stimulation. That is precisely why, throughout a treatment protocol, ultrasounds and hormonal tests play the role of adjusting medication and reducing the likelihood of an excessive reaction. For people who want to better understand the stages of treatment, a complete guide about in vitro fertilization can provide the necessary context regarding ovarian monitoring and the medical decisions made along the way.

How It Manifests: Mild, Moderate and Severe Symptoms

The manifestations may vary greatly from one case to another. In mild forms, ovarian hyperstimulation syndrome may cause bloating, abdominal discomfort, a feeling of pelvic tension, mild nausea or slight weight gain. These symptoms may appear after stimulation or after egg retrieval and, in many cases, gradually improve with relative rest, balanced hydration and monitoring.

In moderate forms, the clinical picture becomes clearer: the abdomen may become visibly enlarged, the pain intensifies and nausea, vomiting, reduced urine output or an altered general condition may appear. Severe forms are rarer, but require rapid evaluation, because they may be accompanied by significant fluid accumulation, breathing difficulties, dehydration, coagulation disorders or impaired kidney function. These signs should not be minimized, especially if they appear suddenly or worsen within a few days.

An important element is the timing of symptom onset. Sometimes, symptoms begin a few days after egg retrieval. Other times, they may intensify if pregnancy occurs, because hormonal changes may prolong or worsen the course. For this reason, the recommendations received from the clinic after ovarian puncture must be followed carefully and any significant change must be communicated to the medical team.

How Treatment Is Established and When Urgent Consultation Is Necessary

Treatment depends on the severity of the symptoms. In mild forms, management is usually conservative: supervision, clinical check-up, evaluation of urine output, weight monitoring and clear recommendations regarding hydration and physical activity. In general, intense effort and sexual intercourse are avoided, because the ovaries may be enlarged and more vulnerable.

In moderate or severe forms, blood tests, ultrasound, symptomatic treatment, correction of fluid imbalances and, in some cases, hospitalization may be necessary. The goal is not only to relieve discomfort, but above all to prevent complications. Guidelines from specialist societies underline the importance of prevention and careful selection of the stimulation protocol, so that the patient is monitored individually even before symptoms appear.

Urgent medical consultation is recommended if significant abdominal pain, a very enlarged abdomen, persistent vomiting, breathing difficulties, dizziness, very low urine output or very dark urine or rapid weight gain over a short period appear. Within a broader therapeutic pathway, especially for patients considering access to public funding, information about eligibility and administrative steps may also be followed in the National IVF Program 2025 – complete guide, respectively on the page dedicated to the National IVF Program 2026, where these are relevant for treatment planning.

“You deserve to be listened to, seen, treated with respect and supported throughout life.”

Andreas Vythoulkas

Specialist in Obstetrics and Gynecology

Frequently Asked Questions

Does ovarian hyperstimulation syndrome occur only in IVF?
No exclusively, but it is most frequently discussed in connection with assisted reproduction treatments that involve ovarian stimulation. The risk depends on the type of protocol, the ovarian response and the characteristics of each patient.

Do all patients with ovarian hyperstimulation syndrome end up in the hospital?
No. Many cases are mild and can be monitored on an outpatient basis, with clear recommendations and permanent contact with the medical team. Moderate and severe forms are the ones that may require additional investigations or hospitalization.

Can ovarian hyperstimulation syndrome be completely prevented?
There is no absolute guarantee, but the risk can be reduced through careful selection of the protocol, ultrasound and hormonal monitoring and treatment adjustment when the ovarian response is very strong.

Does ovarian hyperstimulation syndrome affect the chances of treatment?
It depends on the severity and the moment of onset. In some situations, the doctor may recommend postponing embryo transfer and continuing treatment in a safer setting, in order to protect the patient’s health and optimize clinical management.

Why Choose Genesis Athens for the Evaluation and Monitoring of the Risk of Ovarian Hyperstimulation

At Genesis Athens, the evaluation of patients undergoing assisted reproduction treatments is carried out in a clinical setting oriented toward safety, careful monitoring and individualized medical decisions. In the case of the risk of ovarian hyperstimulation syndrome, what matters is not only the response when symptoms appear, but also prevention: choosing the right protocol, correctly interpreting the ovarian response and adjusting management in time.

The institutional approach involves integrating investigations, clinical supervision and clear communication with the patient throughout the treatment. In this way, information related to symptoms, progression and next steps is provided in a balanced, accessible and medically responsible way, without unnecessary alarm, but without underestimating the signs that may indicate a complication.

Contact a specialist

Talk to a specialist about
Ovarian Hyperstimulation Syndrome

If you have questions related to Ovarian Hyperstimulation Syndrome or you are concerned about your fertility, our patient support team is here to offer the support and guidance you need.

Talk to a specialist now

Sources:

• RCOG – Ovarian hyperstimulation syndrome (informații pentru paciente)
• ASRM – Prevention of moderate and severe ovarian hyperstimulation syndrome: guideline
• RCOG – The Management of Ovarian Hyperstimulation Syndrome
• MedlinePlus – Ovarian hyperstimulation syndrome
• NHS patient information – Ovarian Hyperstimulation Syndrome (OHSS)